Integrated genome and transcriptome analyses solves about one third of the patients with rare developmental disorders and negative first-line molecular investigations

Archive ouverte

Vitobello, A. | Mau-Them, F. T. | Bruel, A. L. | Duffourd, Y. | Tisserant, E. | Callier, P. | Moutton, S. | Nambot, S. | Lehalle, D. | Jean-Marcais, N. | Delanne, J. | Racine, C. | Thevenon, J. | Poe, C. | Jouan, T. | Chevarin, M. | Willems, M. | Coubes, C. | Genevieve, D. | Houcinat, N. | Masurel-Paulet, A. | Mosca-Boidron, A. | Sorlin, A. | Isidor, Bertrand | Heide, S. | Afenjar, A. | Rodriguez, D. | Mignot, C. | Heron, D. | Vincent, M. | Charles, P. | Odent, S. | Dubourg, C. | Faudet, A. | Keren, B. | Cogné, Benjamin | Boland, Anne | Olaso, Robert | Philippe, C. | Deleuze, Jean-François | Faivre, L. | Thauvin-Robinet, C.

Edité par CCSD ; Nature Publishing Group -

International audience. Exome sequencing (ES) represents the first-tier diagnostic test in patients presenting with syndromic developmental delay with suspected monogenic etiology. Yet, about 50% of these patients remain unsolved, arguing the interest to extend the genetic investigations beyond the protein-coding genome and to integrate multi-omics approaches. We launched a multi-centric pilot study gathering 53 unsolved patients, after trio ES and array-CGH results, presenting with heterogeneous mild to severe syndromic intellectual disabilities. We performed genome sequencing (GS) combined with transcriptome analysis, highlighting a molecular cause in 32% of the cohort (18/53 patients). GS identified 7 causative structural variants, including 1 deletion, 2 balanced inversions, 1 balanced translocation and 3 complex variants. The molecular readouts of such variants were all validated and furtherly investigated by RNAseq. One deep intronic SNV causing the activation of a cryptic exon, changing the open reading frame of the transcript, was detected by RNAseq. Two frameshift-causing indels were identified in protein-coding regions not captured by ES. Three variants were identified in genes not yet known as disease-causing at the time of the ES analysis. Finally, genotype-phenotype correlation could establish 3 additional diagnoses not identified during the ES analysis. In addition, we detected 2 complex structural variants of unknown significance, not resolvable by short-read GS, as well as new candidate genes identified through RNA-seq differential expression analysis. Overall, GS and RNAseq analyses allowed the identification of the molecular mechanisms underlying 1/3 of previously unsolved patients, and additional candidate variants requiring further investigation (3rd-generation sequencing, 3C techniques) to demonstrate their causality.

Consulter en ligne

Suggestions

Du même auteur

Integrated genome and transcriptome analyses solves about one third of the patients with rare developmental disorders and negative first-line molecular investigations

Archive ouverte | Vitobello, A. | CCSD

International audience

Fast genome sequencing in less than 40 days for newborn patients in intensive care unit: a feasibility study allowing diagnosis in 56% of cases in a French hospital network

Archive ouverte | Denomme-Pichon, A. | CCSD

International audience

Prospective interest in deploying multi-omics approaches to solve unsolved patients with suspected monogenic developmental delay syndromes

Archive ouverte | Duffourd, Y. | CCSD

International audience

Chargement des enrichissements...